Developmental characteristics of phenylethanolamine and octopamine in the rat brain.
D000375:Aging; D000818:Animals; D000831:Animals, Newborn; D001921:Brain / Q000187:drug effects / Q000201:enzymology / Q000254:growth & development / Q000378:metabolism*; D002855:Chromatography, Thin Layer; D004299:Dopamine beta-Hydroxylase / Q000378:metabolism; D004983:Ethanolamines / Q000378:metabolism*; D005260:Female; D010134:Fenclonine / Q000494:pharmacology; D005333:Fetus; D005865:Gestational Age; D007490:Iproniazid / Q000494:pharmacology; D008995:Monoamine Oxidase / Q000378:metabolism; D009638:Norepinephrine / Q000378:metabolism; D009655:Octopamine / Q000378:metabolism*; D010627:Phenethylamines / Q000378:metabolism*; D010625:Phenylethanolamine N-Methyltransferase / Q000378:metabolism; D011247:Pregnancy; D051381:Rats; D012436:S-Adenosylmethionine; D013997:Time Factors; D014316:Tritium; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism
D004983:Ethanolamines; D010627:Phenethylamines; D014316:Tritium; D009655:Octopamine; D012436:S-Adenosylmethionine; D007490:Iproniazid; D014446:Tyrosine 3-Monooxygenase; D004299:Dopamine beta-Hydroxylase; D008995:Monoamine Oxidase; D010625:Phenylethanolamine N-Methyltransferase; D010134:Fenclonine; D009638:Norepinephrine